MD - Mednax Inc

MD - Mednax Inc

https://www.pediatrix.com

Buy Momentum: Bearish

Recent News

Powered by Alpha Vantage

Here's Why Pediatrix Medical Shares Are Attracting Investors Now

Zacks Commentary • 2 days, 21 hours ago • score: 0.23

MD shares surge on strong earnings, rising revenues, cost cuts and a new $250M buyback plan.

Despite Fast-paced Momentum, Pediatrix Medical Group ( MD ) Is Still a Bargain Stock

Zacks Commentary • 1 week, 5 days ago • score: 0.45

Pediatrix Medical Group (MD) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Should You Buy Pediatrix Medical Group ( MD ) After Golden Cross?

Zacks Commentary • 2 weeks, 3 days ago • score: 0.62

Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Zacks Commentary • 2 weeks, 3 days ago • score: 0.43

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Pediatrix Medical Refills Its Buyback Prescription With $250M Dose

Zacks Commentary • 3 weeks, 6 days ago • score: 0.46

MD launches a $250M buyback, fueled by stronger cash flow, leaner operations and robust 2025 profit outlook.

Pediatrix Medical Group ( MD ) Is Up 11.93% in One Week: What You Should Know

Zacks Commentary • 3 weeks, 6 days ago • score: 0.45

Does Pediatrix Medical Group (MD) have what it takes to be a top stock pick for momentum investors? Let's find out.

Pediatrix Medical Group ( MD ) Is Attractively Priced Despite Fast-paced Momentum

Zacks Commentary • 1 month ago • score: 0.49

Pediatrix Medical Group (MD) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

MEDNAX, Inc., provides neonatal, maternal-fetal, pediatric cardiology, and other pediatric subspecialties in the United States and Puerto Rico. The company is headquartered in Sunrise, Florida.

52W High

$17.67

52W Low

$10.06

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

1.30

Valuation

Attractive

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

13.13

Forward P/E (<15 better)

9.31

EV/EBITDA (<8 favorable)

8.78

EV/Revenue (<3 favorable)

0.92

P/S (TTM) (<3 favorable)

0.77

P/B (<3 favorable)

1.78

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

2.12%

Institutions (25–75% balanced)

97.31%

Shares Outstanding

87,084,000

Float

84,220,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

1,940,725,000

Gross Profit (TTM)

472,717,000

EPS (TTM)

1.30

Profit Margin (>10% good)

0.06%

Operating Margin (TTM) (higher better)

0.14%

ROE (TTM) (>15% strong)

0.14%

EPS YoY (Quarterly) (>10% good)

3.93

Revenue YoY (Quarterly) (>8% good)

-0.07

Momentum

Bearish momentum

Value

0.6490

Previous

0.7238

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025